Advertisement

Connective Tissue Changes

  • Mark Brincat
  • Ray Galea
Part of the Medical Science Symposia Series book series (MSSS, volume 11)

Abstract

The menopause constitutes a watershed in a woman’s life that leads to profound changes in several systems. As the realization of the multisystem nature of these changes, ranging from psychological to bone to cardiovascular, has developed, so also has the awareness that many of these changes can be prevented or completely modified with therapy. The mainstay of this therapy continues to be the appropriate use of estrogen.

Keywords

Postmenopausal Woman Hormone Replacement Therapy Postmenopausal Osteoporosis Estrogen Deficiency Urethral Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gordon T, Castelli WP, Hjorteand MC, Kannal WO, Dauber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977;62:707–14.PubMedCrossRefGoogle Scholar
  2. 2.
    Hammond CB, Jelovsek FR, Lee KC, Creasman WT, Parker RJ. Effects of long term estrogen replacement therapy. 1. Metabolic effects. Am J Obstet Gynecol 1979;133:525–35.PubMedGoogle Scholar
  3. 3.
    Ross RK, Paganini-Hill A, Mack TN, et al. Menopausal estrogen therapy and protection from death from ischeamic heart disease. Lancet 1981;i:858–61.CrossRefGoogle Scholar
  4. 4.
    Stampfer MJ, Willett WC, Colditz JA, et al. A prospective study of postmenopausal estrogen therapy and coronary heart disease. New Engl J Med 1985;313:1044.PubMedCrossRefGoogle Scholar
  5. 5.
    Bush TL, Barrett-Connor E, Cowan LD et al. Cardiovascular mortality and non-contraceptive use of oestrogen in women: Results from the Lipid Research Clinic’s Programme follow-up study. Circulation 1987;75:1102.PubMedCrossRefGoogle Scholar
  6. 6.
    Wilson PWF, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking and cardiovascular morbidity in women over 50.The Framingham study. New Engl J Med 1985;313:1038.PubMedCrossRefGoogle Scholar
  7. 7.
    Tikkannen MJ, Nikkila EA, Kunsi T. Lipids, hormonal status and the cardiovascular system in the menopause. In: Greenblatt RB, editor. A Modern Approach to the Perimenopausal Years. Berlin: Walter de Gruyter, 1986:77–86.Google Scholar
  8. 8.
    Crook D, Godsland IF, Wynn V. Ovarian hormones and plasma lipoproteins. The Menopause 1988;15:168–80.Google Scholar
  9. 9.
    Studd JWW, Thorn MH, Paterson NEL, Wade-Evans T. The prevention and treatment of endometrial pathology in postmenopausal women receiving exogenous estrogens. In: Pasetto N, Paoletti R, Ambrvs JL, editors. The menopause and postmenopause. Lancaster: MTP Press, 1980:127–39.CrossRefGoogle Scholar
  10. 10.
    Magos AL, Brincat M, Studd JWW, et al. Amenorrhoea and endometrial atrophy with continuous oral oestrogen and progestogen therapy in postmenopausal women. Obstet Gynaecol 1985;65:496–99.Google Scholar
  11. 11.
    Muscat-Baron Y, Brincat M, Galea R. Carotid artery wall thickness in postmenopausal women treated with hormone replacement therapy. Proceedings 8th International Congress on the Menopause. 1996 Nov 4–7 Sydney Australia.Google Scholar
  12. 12.
    Rodriguez K, Naessen T. Is the arterial wall composition preserved by estrogens? A comparative study between long-term users, age matched controls and young women. Proceedings 8th International Congress on the Menopause. 1996 Nov 4–-7 Sydney Australia.Google Scholar
  13. 13.
    Gordan GS. Prevention of bone loss and fractures in women. Maturitas 1984;6:225–42.PubMedCrossRefGoogle Scholar
  14. 14.
    Bruns P. Die allgemaine lebra von der knochenbruchen. Deutshe Chirvrgie 1982;27:1–400.Google Scholar
  15. 15.
    Albright F, Smith PH, Richardson AM. Postmenopausal osteoporosis — its clinical features. JAMA 1941;116:2465–74.CrossRefGoogle Scholar
  16. 16.
    Nordin BEC, Aaron J, Speed R, Crilly RG. Bone formation and resorption as the determinants of trabecular bone volume in postmenopausal osteoporosis. Lancet 1981;ii:227–95.Google Scholar
  17. 17.
    Brincat M, Moniz CJ, Studd JWW, et al. Long term effects of the menopause and sex hormones on skin thickness. Br J Obstet Gynaecol 1985;92:256–59.PubMedCrossRefGoogle Scholar
  18. 18.
    Brincat M, Moniz CF, Kabalan S, et al. Decline in skin collagen content and metacarpal index after the menopause and its prevention with sex hormone replacement. Br J Obstet Gynaecol 1987;94:126–29.PubMedCrossRefGoogle Scholar
  19. 19.
    Nordin BEC. Osteomalacia, osteoporosis and calcium deficiency. Clin Orthopaedics Rel Res 1960;17:235–58.Google Scholar
  20. 20.
    Stevenson JC, Whitehead MI. Postmenopausal osteoporosis. Br Med J 1982;285:585–88.CrossRefGoogle Scholar
  21. 21.
    Chestnut CH. Synthetic salmon calcitonin, diphosphates and anabolic steroids in the treatment of postmenopausal osteoporosis. In: Christiansen C, Arnaud CD, Nordin BEC, Parfitt AM, Peck WA, Riggs BL, editors. Osteoporosis. Proceedings of the Copenhagen International Symposium on Osteoporosis. Aalborg: Stiftsbogtrykkeri, 1984; Vol.2: 549–55.Google Scholar
  22. 22.
    Lindsay R, Hart DH, Purdie D, Ferguson M, Clark AS. Comparative effects of oestrogen and a progestagen on bone loss in postmenopausal women. Clin Science Mol Med 1978;54:193–98.Google Scholar
  23. 23.
    Christiansen C, Christiansen MS, McNain P, Hagen C, Stockland K, Transolol I. Prevention of early menopausal bone loss: Controlled 2-years study in 315 normal females. Eur J Clin Inv 1980;10:273–79.CrossRefGoogle Scholar
  24. 24.
    Natchigall LE, Natchigall RH, Natchigall RD, Bechman E. Estrogen replacement therapy: a 10 year prospective study in the response to osteoporosis. Obstet Gynaecol 1980;53:277–81.Google Scholar
  25. 25.
    Ross RK, Paganini-Hill A, Mack JM. Reduction in fractures and other effects of oestrogen replacement therapy in human population. Osteoporosis. Proceedings of the Copenhagen International Symposium on Osteoporosis. Copenhagen. 1984;1:289–97.Google Scholar
  26. 26.
    Lindsay R, Hart DH, Clark AS. The minimum effect of oestrogen for the prevention of postmenopausal bone loss. Obstet Gynaecol 1984;63:759–62.Google Scholar
  27. 27.
    Sawas M, Studd JWW, Fogelman I, Dooley M, Montgomery J, Murby B. Skeletal effects of oral oestrogen compared with subcutaneous oestrogen and testosterone in postmenopausal women. Br J Med 1988;297:331–33.CrossRefGoogle Scholar
  28. 28.
    Meschia M, Bruschi F, Anicarelli F, Barbacini P, Monza G C, Crosignani P G. Transdermal hormone replacement therapy and skin in postmenopausal women. A placebo controlled study. Menopause: The Journal of the North American Menopause Society 1994;1:79–82.CrossRefGoogle Scholar
  29. 29.
    Brincat M, Studd JWW. Skin and the menopause. The Menopause 1988;8:85–101.Google Scholar
  30. 30.
    Black NM, Shuster S, Bottoms E. Osteoporosis, skin collagen and androgen. Br Med J 1970;4:773–74.PubMedCrossRefGoogle Scholar
  31. 31.
    Stumpf WE, Sur M, Joshi SE. Estrogen target cells in the skin. Experientia 1976;30:196–99.CrossRefGoogle Scholar
  32. 32.
    Kaplan JA. Identification of oestrogen receptors on osteoblast. International Conference on Osteoporosis, Aalburg, 1987 (unpublished abstract).Google Scholar
  33. 33.
    Vashinav R, Gallagher JA, Beresford NN, Russell RGG. Proliferative effects of oestrogens on bone derived cells. Calcif Tissue Int 1984;36(Suppl 2):S59.Google Scholar
  34. 34.
    Shahrad DP, Marks R. A pharmacological effect of oestrone on human epidermis. Br J Dermatol 1977;97:383–86.PubMedCrossRefGoogle Scholar
  35. 35.
    Punnonen R. Effect of castration and peroral therapy on the skin. Acta Obstet Gynaecol Scand 1973;21(Suppl):1–44.Google Scholar
  36. 36.
    Smith P. Age changes in the female urethra. Br J Urology 1972;44:667–76.CrossRefGoogle Scholar
  37. 37.
    Versi E, Cardozo LD. Urethral vascular pulsations. Proceedings of the International Continence Society, London. London. 1985:503–94.Google Scholar
  38. 38.
    Versi E, Cardozo LD, Brincat M, Cooper D, Montgomery JC, Studd JWW. Correlation of urethral physiology and skin collagen in postmenopausal women. Br J Obstet Gynaecol 1988;95:147–52PubMedCrossRefGoogle Scholar
  39. 39.
    Iosif CS, Bekassy Z. Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynaecol Scand 1984;63:257–60.CrossRefGoogle Scholar
  40. 40.
    Osborne JC. Postmenopausal changes in micturition habits and in urine flow and urethral pressure studies. In: Campbell S, editor. The management of the menopause and postmenopausal years. Lancaster. MTP Press, 1976:285–89.CrossRefGoogle Scholar
  41. 41.
    Versi E. The bladder in the menopausal women. In: Greenblatt RB, editor. A modern approach to the perimenopausal years. Berlin: Walter de Gruyter, 1986:93–102.Google Scholar
  42. 42.
    Stanton SL, Oszoy A, Hilton P. Voiding difficulties in the female: Prevalence, clinical and urodynamic review. Obstet Gynaecol 1983;61:144–47.Google Scholar
  43. 43.
    Faber P, Heidenreich J. Treatment of stress incontinence with oestrogen in postmenopausal women. Urologia Int 1977;32:221–23.CrossRefGoogle Scholar
  44. 44.
    Walter S, Wolf I, Barlebo H, Jensen HK. Urinary incontinence in postmenopausal women treated with oestrogens. A double blind clinical trial. Urologia Int 1978;33:136–43.Google Scholar
  45. 45.
    Hilton P, Stanton SL. The use of intravaginal oestrogen cream in genuine stress incontinence with oestrogen in postmenopausal women. Urologia Int 1983;32:221–23.Google Scholar
  46. 46.
    Brincat M, Versi E, Studd JWW, et al. Skin collagen changes in postmenopausal women receiving different regimes of oestrogen therapy. Obstet Gynaecol 1987;70:123–27.Google Scholar
  47. 47.
    Uzaka M, Nakamiza K, Ohta S, Mori Y. Induction of hyaluronic acid synthetase by oestrogen in the mouse skin. Biochem Biophys Acta 1981;673:387–93.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1997

Authors and Affiliations

  • Mark Brincat
  • Ray Galea

There are no affiliations available

Personalised recommendations